Determine exposure and immunity in 15 minutes or less.
US FDA Emergency Use Approved & CE Marked Rapid Diagnostic Solution SARS – nCoV-19 IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of IgG anti–nCoV-19 virus and IgM anti-nCoV-19 virus in human whole blood, serum or plasma.
It is intended to be used by the professionals as a screening test and as an aid in the diagnosis of infection with nCoV-19 viruses.
The nCoV19 IgG/IgM RapidTest Device is a qualitative membrane-based immunoassay for the detection of nCoV-19 antibodies in whole blood, serum, or plasma.
This test consists of two components, an IgG component and an IgM component. TheTest region is coated with anti-human IgM and IgG. During testing, the specimen reacts with nCoV-19antigen-coated particles in the test strip.
The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgM or IgG in test line region.
If the specimen contains IgM or IgG antibodies to nCoV-19, a colored line will appear in test line region. Therefore, if the specimen contains nCoV-19 IgM antibodies, a colored line will appear in test line region M.
If the specimen contains nCoV19 IgG antibodies, a colored line will appear in test line region G. If the specimen does not contain nCoV-19 antibodies, no colored line will appear in either of the test line regions, indicating a negative result.
To serve as a procedural control, a colored line will always appeare in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
- Test cassette
- Buffer/ Reagent solution
- Disposable pipettes – For adding specimens and reagent
- Alcohol pad
- Package insert – For operation instructions
Available in complete kits of 25